Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc.

SBFM | NASDAQ
Chart Builder DCF Calculator
$0.91
+$0.01 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$0.97
+$0.06 (+6.24%)
Pre-market: Sep 22, 2026, 4:16 AM ET

Market Data

Market Cap
$2.14M
Enterprise Value
$-11.59M
Beta
1.32
Average Volume
1.66M
Shares Outstanding (Diluted)
1.37M
Shares Change YoY
5973.24%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US8677818093

Price Performance

Price Change 1M
-20.9%
Price Change 3M
-55.4%
Price Change 6M
-91.2%
Price Change YTD
-92.9%
Price Change 1Y
-94.0%
Price Change 3Y
-100.0%
Price Change 5Y
-100.0%
1M CAGR (ann.)
-35.7%
1Y CAGR (ann.)
-93.9%
5Y CAGR (ann.)
-90.4%
All-Time CAGR
-69.3%

Valuation

PE Ratio
-0.09
Forward PE
33.18
PEG Ratio
-0.00
Forward PEG
0.00
PS Ratio
0.06
Forward PS
0.00
PB Ratio
0.08
P/FCF Ratio
-0.47
P/Adj. FCF Ratio
-0.47
P/OCF Ratio
-0.23
EV/Sales
-0.33
EV/EBIT
2.07
EV/EBITDA
2.20
EV/FCF
2.52
Earnings Yield
-1115.4%
FCF Yield
-212.7%
Adj. FCF Yield
-212.7%

Financial Health

Net Cash
$13.75M
Total Debt
$0
Cash & Short-Term Investments
$13.75M
Total Assets
$2.97M
Current Ratio
5.46
Quick Ratio
3.30
Debt / Equity Ratio
0.02
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-18.22
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
29.8%
Operating Profit Margin
-14.7%
EBITDA Margin
-14.9%
Net Profit Margin
-16.5%
FCF Margin
-13.0%
Adj. FCF Margin
-13.0%
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
-17.3%
Return on Equity
-24.2%
Return on Invested Capital
-18.4%
Return on Capital Employed
-18.6%
Return on Tangible Assets
-18.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
34.5%
Revenue CAGR 5Y
203.1%
Revenue CAGR 10Y
39.6%
EPS CAGR 3Y
141.7%
EPS CAGR 5Y
91.0%
EPS CAGR 10Y
52.0%
FCF CAGR 3Y
41.7%
FCF CAGR 5Y
-4.5%
FCF CAGR 10Y
-27.2%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
1
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$7
Price Target Upside
669.2%

Cash Flow

Operating Cash Flow
$-5.33M
Free Cash Flow
$-4.6M
Adj. Free Cash Flow
$-4.6M
FCF Per Share
-$3.37
OCF Per Share
-$3.91
OCF/S Ratio
-15.1%

Income Statement

Revenue
$35.35M
Gross Profit
$10.53M
Operating Income
$-5.2M
EBITDA
$-5.26M
Net Income
$-5.83M
EPS (Diluted)
-$10.15
Revenue / Employee
$706.94K
Profit / Employee
$-116.65K
Employees
50

© 2026 bestshares.com. All rights reserved.